Phase 4 Lymphoblastic Leukemia Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Acute Lymphoblastic LeukemiaMixed Phenotype Acute LeukemiaLymphoblastic Lymphoma
St. Jude Children's Research Hospital850 enrolled3 locationsNCT06289673
Recruiting
Phase 4
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Acute Lymphoblastic LeukemiaAcute Myeloblastic LeukemiaNeutropenic Fever
Gadjah Mada University120 enrolled1 locationNCT07016165
Recruiting
Phase 4
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaLeukaemia (Acute)
Ain Shams University42 enrolled2 locationsNCT06918054
Recruiting
Phase 4
Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Acute B-cell Lymphoblastic Leukemia
Suping ZHANG60 enrolled1 locationNCT06339775
Recruiting
Phase 4
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
Acute Lymphoblastic Leukemia
Swiss Pediatric Oncology Group1,000 enrolled4 locationsNCT02670564